Pages that link to "Q63279445"
Jump to navigation
Jump to search
The following pages link to anticoagulation (Q63279445):
Displaying 50 items.
- May–Thurner syndrome (Q605576) (← links)
- A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines (Q21090750) (← links)
- New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons (Q21132464) (← links)
- Educational intervention improves anticoagulation control in atrial fibrillation patients: the TREAT randomised trial (Q21132512) (← links)
- Legal and professional implications of shared care: a case study in oral anticoagulation stroke prevention therapy (Q21146694) (← links)
- A heparin binding synthetic peptide from human HIP / RPL29 fails to specifically differentiate between anticoagulantly active and inactive species of heparin (Q21245645) (← links)
- Parenteral anticoagulation in ambulatory patients with cancer (Q22252972) (← links)
- Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials (Q22306362) (← links)
- An economic model of adverse events and costs for oral anticoagulants used for atrial fibrillation (Q23914009) (← links)
- Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm (Q24185800) (← links)
- Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome (Q24185813) (← links)
- Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease (Q24185924) (← links)
- Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome (Q24188639) (← links)
- Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair (Q24185998) (← links)
- Anticoagulant treatment for subsegmental pulmonary embolism (Q24186514) (← links)
- Anticoagulants for acute ischaemic stroke (Q24187310) (← links)
- Anticoagulation for people receiving long-term haemodialysis (Q24187603) (← links)
- New oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease (Q24192938) (← links)
- Anticoagulation for people with cancer and central venous catheters (Q24193103) (← links)
- Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer (Q24193871) (← links)
- Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation (Q24194116) (← links)
- Anticoagulation therapy versus placebo for pulmonary hypertension (Q24194138) (← links)
- Vitamin K for improved anticoagulation control in patients receiving warfarin (Q24194649) (← links)
- Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication (Q24194752) (← links)
- Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer (Q24194904) (← links)
- Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation (Q24194926) (← links)
- Anticoagulant treatment for subsegmental pulmonary embolism (Q24194990) (← links)
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism (Q24197581) (← links)
- Anticoagulant treatment for subsegmental pulmonary embolism (Q24197722) (← links)
- Anticoagulation versus placebo for heart failure in sinus rhythm (Q24197822) (← links)
- Anticoagulation therapy versus placebo for pulmonary hypertension (Q24200875) (← links)
- Antiplatelet and anticoagulation for patients with prosthetic heart valves (Q24201287) (← links)
- Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment (Q24201432) (← links)
- Optimal loading dose of warfarin for the initiation of oral anticoagulation (Q24202077) (← links)
- Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation (Q24202280) (← links)
- Anticoagulation versus placebo for heart failure in sinus rhythm (Q24202686) (← links)
- Vitamin K for improved anticoagulation control in patients receiving warfarin (Q24202915) (← links)
- Low molecular weight heparin (LMWH) versus unfractionated heparin (UFH) for haemodialysis anticoagulation (Q24203624) (← links)
- Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease (Q24203776) (← links)
- Oral anticoagulants versus antiplatelet therapy for preventing stroke and systemic embolic events in patients with atrial fibrillation (Q24203797) (← links)
- Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer (Q24234155) (← links)
- Antiplatelet agents and anticoagulants for hypertension (Q24234617) (← links)
- Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation (Q24234691) (← links)
- Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy (Q24234729) (← links)
- Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation (Q24234857) (← links)
- Anticoagulation for cerebral venous sinus thrombosis (Q24234897) (← links)
- Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation (Q24235112) (← links)
- Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer (Q24235193) (← links)
- Anticoagulation for patients with cancer and central venous catheters (Q24235260) (← links)
- Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation (Q24235785) (← links)